COMPREHESIVE, COMPATIBLE
PORTFOLIOS
At Medtronic, we are always innovating to provide you with meaningful tools and technologies so you can do more for your stroke patients. Our comprehensive portfolio provides you with Neurovascular solutions that advance and enhance care.
INNOVATIVE,
INTEGRATED
SOLUTIONS
In addition, we continuously pursue strategic partnerships that round out the continuum of care giving patients the holistic care they deserve through our innovative, integrated solutions.
PARTNERSHIPS TO ADVANCE STROKE TREATMENT
Medtronic has joined forces with these innovative companies to elevate stroke treatment and enhance your expertise.
VIZ.AI
ACCELERATE STROKE SYSTEM CARE
By teaming up with Viz.ai, we now offer a more comprehensive stroke solution by synchronizing stroke care and improving access to treatment. Viz.ai uses artificial intelligence to detect suspected Large Vessel Occlusions and triage patients directly to the stroke team on call, within minutes.1
Using your mobile device, you can conveniently:
- Review CT images
- Communicate via a HIPAA-compliant texting and calling platform
- Coordinate patient care, facilitate transfers and initiate treatment
SIM&CURE
PATIENT-SPECIFIC PRE-OPERATIVE PLANNING
Medtronic has joined forces with Sim&Cure to bring you a Sim&Size,* a unique, pre-operative planning software platform, enabling you to computationally model and plan your Pipeline™ Flex embolization device procedures with a patient-specific surgical strategy.
With Sim&Size,2 you can consider your patients’ specific anatomy before the procedure with:
- Optimized device selection2
- Facilitated device placement2
- Visualization of proximal and distal landing zones
ADVANCING STROKE TREATMENT, TOGETHER
When you partner with Medtronic, we empower you with an unparalleled portfolio of Neurovascular technologies, and innovative, integrated solutions like Viz.ai and Sim&Cure. With your expertise and our technology and support, we can advance stroke treatment, together.
Sim&Size is a 510(k) K190049 cleared software developed by Sim&Cure. Refer to Sim&Size User Manual for complete indications for use, contraindications, warnings and instructions for use. Sim&Size is contraindicated for giant aneurysms.
FDA De Novo DEN170073, Core Lab Study, 2 Centers, n=44, Sensitivity 87.8%. Specificity 89.6%. 2017.
Ospel, Johanna & Gascou, Gregory & Costalat, V. & Piergallini, L. & Blackham, Kristine & Zumofen, Daniel. (2019). Comparison of Pipeline Embolization Device Sizing Based on Conventional 2D Measurements and Virtual Simulation Using the Sim&Size Software: An Agreement Study. American Journal of Neuroradiology. 40. 10.3174/ajnr.A5973.
© 2020 Medtronic. All rights reserved. Medtronic, Medtronic logo and Further, Together are trademarks of Medtronic. ™* Third party brands are trademarks of their respective owners. All other brands are trademarks of a Medtronic company.